Revolutionizing Production in the Biotech Industry: The Impact of Werum IT Solutions

Author picture

Share On:

Facebook
Twitter
LinkedIn

Werum IT Solutions is a company that provides manufacturing execution systems (MES) for the pharmaceutical and biotech industry. The digital revolution and industrialization have significantly impacted the pharma and biotech market, providing opportunities for all market players but also creating challenges such as increasing quality and regulatory requirements, shrinking batch sizes, and demand for cost-efficient solutions. To solve these production challenges, Werum provides an efficient, functionally complete, and user-friendly MES called PAS-X. The software products offered by Werum help pharma and biotech companies increase their manufacturing efficiency and productivity, benefitting from high-quality and cost savings while maintaining a sustainable competitive advantage in the market.

With the COVID-19 pandemic, the importance of electronic and computer-aided manufacturing execution systems has become more significant than ever as paper-based production workflows in a pharmaceutical manufacturing environment are slow, error-prone and cannot be executed remotely. Werum is well-positioned to provide its customers with MES software projects that can be executed remotely. The company anticipates a huge demand for its software and consulting offers after the pandemic as only computer-aided manufacturing of medicines enables a rapid and efficient response to unforeseen events such as COVID-19.

Werum has been providing specialized and innovative solutions in pharma and biotech for more than 30 years, offering a full-scope MES solution comprising the PAS-X software product and pre-configured content for pharmaceutical and biotech processes. Werum’s manufacturing IT portfolio is complemented by Enterprise Manufacturing Intelligence (EMI) solutions for easy data acquisition and advanced decision making. The company also provides remarkable new offerings such as its biometric authentication product K.ME-IN to simplify login and signing processes, PAS-X MSI Plug & Produce for fast and easy level 2 integration, and an integrated solution for detailed scheduling based on sedApta’s Factory Scheduler and Augmented Reality (AR) driven shop floor operations for more efficiency and quality.

Jens Woehlbier, the CEO of Werum IT Solutions, is actively driving forward the further development of Werum’s product portfolio. He is enthusiastic about technology and likes to try out new technologies with curiosity in his private and professional life. The company uses state-of-the-art techniques and tools for networking and communication in its daily work. The CEO is in regular contact with all employees around the globe through CEO Talks, an interactive web conference, and other activities to keep in touch online and successfully motivate the employees.

The roots of Werum IT Solutions trace back to 1969 when the software pioneer Wulf Werum founded the company in Germany, which focused on system software. The company started concentrating on the pharmaceutical industry in the early 1990s and soon became the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions. Today, Werum is the leading strategic partner of the pharma, biotech, and cell & gene therapy industry worldwide, with the majority of the world’s top 30 pharmaceutical and biotech companies and many medium-sized customers around the globe running PAS-X.

Werum aims to apply and derive the benefits of Industry 4.0 to pharmaceutical production environments. The company strives to generate competitive advantages to its customers in the pharma, biotech, and cell & gene therapy industries through its innovative Industry 4.0 technologies. Recently, Werum acquired Exputec, a company focused on data-based process analysis and consulting in the biotech industry, to extend its PAS-X MES and EMI solutions. With inCyght, a proven bioprocess data science solution, customers can accelerate the development of their biopharmaceutical pipeline, improve the speed and regulatory success of new product commercialization, and optimize productivity.

Related Posts
Latest Magazines
Recent Posts